This journey is not about skinny, it is about health

For Dr Alexandra Sowa, author of The Ozempic Revolution, getting onto GLP-1 drugs is not a fad but a lifelong decision

- Sanjukta Sharma

An obesity and internal medicine specialist based in New York, Dr Alexandra Sowa has been researching and practicing obesity medicine for about a decade now. For her—and her practice at her company So Well—Ozempic is not much of a revolution. But her new book belies that familiarity. Titled The Ozempic Revolution, it's the first comprehensive user guide to GLP-1s—from the science and pop culture resonances of weight loss drugs and detailed guides to optimizing benefits. "The thing you need to know is, a prescription does not just mean success on these medications. You need to know how to thrive: How to eat, think, live and most importantly, how to change your relationship with food," she says. In an interview over Zoom, Sowa spoke to Mint about her experiences with the drug, what gives Mounjaro an extra edge over other GLP-1s, and how these weight loss medications could be beneficial to women.

Edited excerpts:

Recently, a mildly overweight friend casually said she was considering Mounjaro. Who is the ideal candidate for this kind of drug?